A distinctive subgroup of oral EBV+ B-cell neoplasm with polymorphous features is potentially identical to EBV+ mucocutaneous ulcer
Human Pathology Oct 12, 2017
Ohata Y, et al. - This trial was designed with the aim of better characterizing and grasping the pathophysiology of diffuse large B-cell lymphoma (DLBCL) and EBV-positive mucocutaneous ulcer (EBVMCU) in the oral cavity. Based on the results it was determined that oral EBV-positive B-cell lymphoid proliferation with polymorphous characteristics frequently fulfilled the criteria for EBVMCU. They displayed clinicopathologically and genetically distinctive properties.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
